Oxford biotech firm secures £13.2m to develop world’s first treatment for rare, incurable and deadly disease

A UK biotech company has announced £13m of investment that they believe will fund them through to clinical trials next year of the world’s first treatment for a rare, incurable and deadly disease. The investment has been raised by Oxfordshire-based SynaptixBio, whose aim is to tackle TUBB4a leukodystrophy – a genetic and debilitating condition that mainly…

Identifying ‘hallmark’ Parkinson’s disease protein build-up could aid early detection and pave way for improved diagnosis and treatment Inbox

A technique that identifies the build-up of abnormal protein deposits linked to Parkinson’s disease could aid in early detection and play a key role in the disease’s clinical diagnosis and characterisation, according to research published in The Lancet Neurology journal. Findings from the study confirm the technique – known as α-synuclein seed amplification assay (αSyn-SAA)…

Children Pay the Price as Life’s Demands Interfere With Breastfeeding

Summary: As fewer Ugandan mothers follow WHO guidance for six months of exclusive breastfeeding, newborns are at risk of infections, stunted growth and malnutrition. Picture credits : Polly Namiyingo, 27, breastfeeds her 5-month-old baby outside her home in Kampala, Uganda, on Oct. 22, 2022. Namiyingo says that breastfeeding her three children has enabled them to remain…

Drug Could Beat Back HIV — If People Could Get It

This story was originally published by Global Press Journal.  ILLUSTRATION BY MATT HANEY, GPJ Summary:  Cabotegravir is a promising HIV prevention medication that’s approved in countries like the United States. But in sub-Saharan Africa, access encounters a number of hurdles. By: Nakisanze Segawa, Global Press Journal Uganda. KAMPALA, UGANDA — Night after night, Annet worries…